Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · IEX Real-Time Price · USD
156.88
+1.20 (0.77%)
At close: Apr 26, 2024, 4:00 PM
159.97
+3.09 (1.97%)
After-hours: Apr 26, 2024, 4:20 PM EDT
Krystal Biotech Employees
Krystal Biotech had 229 employees on February 1, 2024. The number of employees increased by 19 or 9.05% compared to the previous year.
Employees
229
Change (1Y)
19
Growth (1Y)
9.05%
Revenue / Employee
$221,393
Profits / Employee
$47,738
Market Cap
4.44B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Feb 1, 2024 | 229 | 19 | 9.05% |
Feb 20, 2023 | 210 | 91 | 76.47% |
Feb 18, 2022 | 119 | 44 | 58.67% |
Feb 19, 2021 | 75 | 22 | 41.51% |
Feb 28, 2020 | 53 | 16 | 43.24% |
Feb 28, 2019 | 37 | 25 | 208.33% |
Jan 31, 2018 | 12 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
R1 RCM | 30,000 |
Organon & Co. | 10,000 |
Haemonetics | 3,034 |
Doximity | 977 |
Lantheus Holdings | 834 |
BridgeBio Pharma | 550 |
CRISPR Therapeutics AG | 407 |
Madrigal Pharmaceuticals | 376 |
KRYS News
- 1 day ago - Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024 - GlobeNewsWire
- 5 days ago - Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung - GlobeNewsWire
- 23 days ago - Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024 - GlobeNewsWire
- 2 months ago - Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung - GlobeNewsWire
- 2 months ago - Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa - GlobeNewsWire